Protection of methamphetamine nigrostriatal toxicity by dietary selenium

Brain Research

Volumn 851, Issue 1-2, 1999, Pages 76-86

  Kim, Hyoung Chun ^a   Jhoo, Wang Kee ^a   Choi, Dong Young ^a   Im, Doo Hyun ^a   Shin, Eun Joo ^a   Suh, Jeong Hye ^a   Floyd, Robert A ^b   Bing, Guoying ^b  

^a Kangwon National University   (South Korea)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Cu,Zn superoxide dismutase; Dietary selenium; Dopamine; Glutathione peroxidase; Malondialdehyde; Methamphetamine induced neurotoxicity; Oxidative stress; Ratio of reduced glutathione oxidized glutathione

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MALONALDEHYDE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; BODY WEIGHT; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; PARKINSON DISEASE; SELENIUM; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE;

EID: 0033395431     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02122-8     Document Type: Article

References (61)

1. Albers D.S., Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 27:1995;1104-1114.
2. Albers D.S., Zeevalk G.D., Sonsalla P.K. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. Brain Res. 718:1996;217-220.
3. Ben-Shachar D., Eshel G., Riederer P., Youdim M.B.H. Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease. Ann. Neurol. 32:1992;S105-S110.
4. Bing G., Notter M.F., Hansen J.T., Kellogg C., Kordower J.H., Gash D.M. Cografts of adrenal medulla with C6 glioma cells in rats with 6-hydroxydopamine-induced lesions. Neuroscience. 34:1990;687-697.
5. Bing G., Zhang Y., Watanabe Y., McEwen B.S., Stone E.A. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res. 668:1994;261-265.
6. Boadi W.Y., Thaire L., Kerem D., Yannai S. Effects of dietary supplementation with vitamin E, Riboflavin and selenium on central nervous system oxygen toxicity. Pharmacology and Toxicology. 68:1991;77-82.
7. Bostedt H., Schramel P. The importance of selenium in the prenatal and postnatal development of calves and lambs. Biol. Trace Elem. Res. 24:1990;163-171.
8. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Silker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268:1993;1571-1580.
9. Brannan T.S., Marker H.S., Weiss C., Cohen G. Regional distribution of glutathione peroxidase in the adult rat brain. J. Neurochem. 35:1980;1013-1014.
10. Brooksbank B.W., Balazs R. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Dev. Brain Res. 16:1984;37-44.
11. Cadet J.L., Sheng P., Ali S., Rothman R., Carlson E., Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:1994;380-383.
12. Castano A., Cano J., Machado A. Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum. J. Neurochem. 61:1993;1302-1307.
13. Ceballos-Picot I., Nicole A., Briand P., Grimber G., Delacourte A., Defossez A., Javoy-Agid F., Lafon M., Blouin J.L., Sinet P.M. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res. 552:1991;198-214.
14. Chareon-Kawamoto N., Yasumoto K. Selenium deficiency as a cause of overload iron and unbalanced distribution of other minerals. Biosci. Biotechnol. Biochem. 59:1995;302-306.
15. Christensen M.J., Nelson B.L., Wray C.D. Regulation of glutathione-S-transferase gene expression and activity by dietary selenium. Biochem. Biopys. Res. Commun. 202:1994;271-277.
16. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative diorders. Science. 262:1993;689-694.
17. Crapo J.D., McCord J.M., Fridovich I. Preparation and assay of superoxide dismutase. Methods Enzymol. 53:1978;382-393.
18. De Vito M.J., Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1989;1145-1150.
19. Ewan R.C. Effects of selenium on rat growth, growth hormone and diet utilization. J. Nutr. 106:1976;702-709.
20. Floyd R.A. Oxidative damage to behavior during aging. Science. 254:1991;1597.
21. Floyd R.A., Carney J.M. Free Radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32:1992;S22-S27.
22. Forni F., Bassi L., Torraca M., Scalori V., Corsini G.U. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice. Eur. J. Pharmacol. 283:1995;99-102.
23. Giovanni A., Liang L.P., Hastings T.G., Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-18225.
24. Graham D.G., Tiffany S.M., Bell W.R., Gutknecht W.F. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
25. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
26. Heales S.J.R., Davies S.E.C., Bates T.E., Clark J.B. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acethyl aspartate concentration. Neurochem. Res. 20:1995;31-38.
27. Hirata H., Ladenheim B., Rothman R.B., Epstein C., Cadet J.L. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
28. Hirsch E.C. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann. Neurol. 32:1992;S88-S93.
29. Huang H.C., Lee E.H. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic. Biol. Med. 24:1998;76-84.
30. Huang K., Lauridsen E., Clausen J. The uptake of Na-selenite in rat brain. Biol. Trace Elem. Res. 46:1994;91-102.
31. Imam S.Z., Newport G.D., Islam F., Slikker W. Jr., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res. 818:1999;575-578.
32. Jareno E.J., Bosch-Morell F., Fernandez-Delgado R., Donat J., Romero F.J. Serum malondialdehyde in HIV seropositive children. Free Radic. Biol. Med. 24:1998;503-506.
33. Jimenez-Jimenez F.J., Molina J.A., Arrieta F.J., Aguilar M.V., Cabrera-Baldivida F., Vazquez A., Jorge-Santamaria A., Seijas V., Fernandez-Calle P., Marinez-Para M.C. Decreased serum selenium concentrations in patients with Parkinson's disease. Eur. J. Neurol. 2:1995;111-114.
34. Kish S.J., Morito C., Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neurosci. Lett. 58:1985;343-346.
35. Kogan F.J., Nichols W.K., Gibb J.W. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36:1976;363-371.
36. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium deficient rat liver. Biochem. Biophys. Res. Commun. 71:1976;952-958.
37. Lawrence R.A., Parkhill L.K., Burk R.F. Hepatic cytosolic non-selenium-dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J. Nutr. 108:1978;981-987.
38. Li N.Q., Reddy P.S., Thyagaraju K., Reddy A.P., Hsu B.L., Scholz R., Tu C.P.D., Reddy C.C. Elevation of rat liver mRNA for selenium-dependent glutathione peroxidase by selenium deficiency. J. Biol. Chem. 265:1990;108-113.
39. Li Y., Maher P., Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 19:1997;453-463.
40. McCord J.M., Fridovich I. Superoxide dismutase. Enzymatic function for erythrocuprein. J. Biol. Chem. 244:1969;6049-6055.
41. National Research Council. Neutrient requirement of laboratory animals-mouse. Washington, DC: National Academic Press; 1978; 38-53.
42. Perry T.L., Godin D.V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:1982;305-310.
43. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., Carson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resist to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667.
44. Rafalowska U., Liu G.L., Floyd R.A. Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid. Free Radic. Biol. Med. 6:1989;485-492.
45. Reed D.J. Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30:1990;603-631.
46. Reed D.J., Babson J.R., Beatty P.W., Ellis W.W., Potter D.W. High pressure liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulphides. Anal. Biochem. 106:1980;55-62.
47. Rollema H., De Vries J.B., Weaterink B.H., Van Putten F.M., Horn A.S. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP. Eur. J. Pharmacol. 132:1986;65-69.
48. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science. 179:1973;588-590.
49. Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., Gibb J.W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233:1985;539-544.
50. Seiden L.S., Vosmer G. Formation of 6-hydroxydopamine in caudate nucleus of the rat after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21:1984;29-31.
51. Sian J., Dexter D.T., Cohen G., Jenner P.G., Marsden C.D. Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in brain. J. Pharm. Pharmacol. 49:1997;332-335.
52. Sinet P.M., Heikkila R.E., Cohen G. Hydrogen peroxide production by rat brain in vivo. J. Neurochem. 34:1980;1421-1428.
53. Slivka A., Cohen G. Hydroxyl radical attack on dopamine. J. Biol. Chem. 260:1985;15466-15472.
54. Sonsalla P.K., Youngster S.K., Kindt M.V., Heikkila R.E. Characteristics of 1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse. J. Pharmacol. Exp. Ther. 242:1987;850-857.
55. Sonsalla P.K., Jochnowitz N.D., Zeevalk G.D., Oostveen J.A., Hall E.D. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res. 738:1996;172-175.
56. Spallholz J.E., Collins G.F., Schwarz A. A single test tube method for the fluorometric microdetermination of selenium. Bioinorg. Chem. 9:1978;453-459.
57. Sutphin M.S., Buckman T.D. Effects of low selenium diets on antioxidant status and MPTP toxicity in mice. Neurochem. Res. 16:1991;1257-1263.
58. Wallach J.D., Lan M., Yu W.H., Gu B.Q., Yu F.T., Goddard R.F. Common denominators in the etiology and pathology of visceral lesions of cystic fibrosis and Keshan disease. Biol. Trace Elem. Res. 24:1990;189-205.
59. Wei Q., Jurma O.P., Anderson J.K. Increased expression of monoamine oxidase-B results in enhanced neurite degeneration in methamphetamine-treated PC12 cells. J. Neurosci. Res. 50:1997;618-626.
60. Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287:1998;107-114.
61. Youdim M.B.H. Iron in the brain: implications for Parkinson's and Alzheimer's disease. Mt. Sinai J. Med. 55:1988;97-101.